Theravance Biopharma
TBPH
TBPH
115 hedge funds and large institutions have $439M invested in Theravance Biopharma in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
30% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 43
Holders
115
Holding in Top 10
4
Calls
$1.18M
Puts
–
Top Buyers
| 1 | +$2.65M | |
| 2 | +$2.64M | |
| 3 | +$2.27M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$1.96M |
| 5 |
Millennium Management
New York
|
+$1.81M |
Top Sellers
| 1 | -$8.19M | |
| 2 | -$5.63M | |
| 3 | -$4.67M | |
| 4 |
BlackRock
New York
|
-$4.44M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.28M |